System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ahead of print

PubMed: 41958072 DOI: 10.1111/bjh.70476

BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study.

Br J Haematol

Authors: Urbain Tauveron-Jalenques, Luca Inchiappa, Jérôme Paillassa, Elsa Maitre, Lise Willems, Nicolas Stocker, Fatiha Merabet, Anne Lok, Diane Lara, Fontanet Bijou, Charles Herbaux, Inès Ramos, Romain Guièze, Cécile Tomowiak, Xavier Troussard

Affiliations

  • Cellular Therapy and Clinical Hematology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • Medical Oncology Department, Centre Antoine Lacassagne, Nice, France.
  • Blood Diseases Department, Angers University Hospital, Angers, France.
  • Laboratory of Hematology, Caen University Hospital, Caen, France.
  • Clinical Hematology Department, Cochin University Hospital-APHP, Paris, France.
  • Clinical Hematology and Cellular Therapy Department, Saint-Antoine University Hospital-APHP, Paris, France.
  • Department of Hematology, Versailles Hospital, Le Chesnay-Rocquencourt, France.
  • Department of Hematology, Nantes University Hospital, Nantes, France.
  • Department of Hematology, Libourne Hospital, Libourne, France.
  • Institut Bergonié, Bordeaux, France.
  • Clinical Hematology Department, Montpellier University Hospital-Montpellier University, Montpellier, France.
  • Institute of Human Genetics, UMR CNRS-UM, Montpellier, France.
  • Biostatistics Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • EA7453 (CHELTER), Clermont Auvergne University, Clermont-Ferrand, France.
  • Hematology and Cellular Therapy Department, Poitiers University Hospital, Poitiers, France.
  • CIC INSERM 1402, Poitiers, France.

MeSH

Cells, Hematology, Rituximab, Vemurafenib